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ABSTRACT: Background. Oral (mobile) tongue squamous cell carci-
noma (SCC) is characterized by a highly variable prognosis in early-stage
disease (T1/T2 N0M0). The ability to classify early oral tongue SCCs into
low-risk and high-risk categories would represent a major advancement
in their management.
Methods. Depth of invasion, tumor budding, histologic risk-assessment
score (HRS), and cancer-associated fibroblast (CAF) density were studied
in 233 cases of T1/T2 N0M0 oral tongue SCC managed in 5 university
hospitals in Finland.
Results. Tumor budding (5 clusters at the invasive front of the tumor)
and depth of invasion (4 mm) were associated with poor prognosis in
patients with early oral tongue SCC (hazard ratio [HR], 2.04; 95% confi-
dence interval [CI], 1.17–3.55; HR, 2.55; 95% CI, 1.25–5.20,
respectively) after multivariate analysis. The HRS and CAF density did
not predict survival. However, high-risk worst pattern of invasion (WPOI),
a component of HRS, was also an independent prognostic factor (HR,
4.47; 95% CI, 1.59–12.51).
Conclusion. Analyzing the depth of invasion, tumor budding, and/or
WPOI in prognostication and treatment planning of T1/T2 N0M0 oral
tongue SCC is recommended.VC 2013 The Authors. Head Neck 36: 811–
818, 2014
KEY WORDS: oral tongue squamous cell carcinoma, tumor budding,
depth of invasion, worst pattern of invasion, histologic risk score,
cancer-associated fibroblast, disease-specific mortality, prognosis
INTRODUCTION
Detection of oral (mobile) tongue squamous cell carci-
noma (SCC) at an early-stage (T1/T2N0M0) does not
always portend good prognosis as evidence shows that
20% to 40% already have occult metastasis at presenta-
tion.1,2 The purpose of prognostic studies in early-stage
mobile tongue cancer is to identify a subset of patients
who are at a risk of adverse outcome, and will therefore
need a more aggressive treatment, such as multimodal-
ity therapy, in contrast with another subset who have
increased chances of a favorable outcome. Local surgi-
cal treatment alone should be adequate for this latter
group.3 Clinical size (T1 or T2) of early oral tongue
SCC (N0) by itself has consistently failed in differenti-
ating these 2 groups.4
The tongue has characteristic structural features includ-
ing a high content of muscle bundles and a rich lymphatic
network that may influence the properties of tumor spread
in it. Current literature includes a number of studies
hypothesizing that histomorphologic parameters may be
used to prognosticate oral tongue SCC and SCC of other
oral subsites and may be helpful in stratifying patients
into low-risk and high-risk categories. We therefore chose
those previously suggested histomorphologic parameters
(depth of tumor invasion, tumor budding, histologic risk
assessment score, and the density of cancer-associated
*Corresponding author: T. Salo, Department of Diagnostics and Oral Medicine,
Institute of Dentistry, University of Oulu, FI-90014, Finland.
E-mail: tuula.salo@oulu.fi
Contract grant sponsor: This study has been funded by the Academy of Finland
and The Finnish Cancer Society.
VC 2013 The Authors. Head & Neck published by Wiley Periodicals, Inc. This
is an open access article under the terms of the Creative Commons Attribu-
tion-Non-Commercial-NoDerivs Licence, which permits use and distribution
in any medium, provided the original work is properly cited, the use is non-
commercial and no modifications or adaptations are made.
HEAD & NECK—DOI 10.1002/HED JUNE 2014 811
fibroblasts) that are easy and practical to evaluate, and
suggested as having important prognostic relevance in
oral tongue SCC. All the parameters used in this study
are defined in the “Methods” section.
Tumor budding is an expression of 2 properties of
malignancy: loss of cellular cohesion and active invasive
movement. It has been associated with poor prognosis in
tongue carcinoma.5 The depth of invasion (or tumor
thickness) is also a measure of tumor invasion.
Brandwein–Gensler et al6 proposed a multiparametric
histologic risk assessment score (HRS) model that was
reported to predict the survival of patients with T1 to T4
oral SCC and capable of differentiating high-risk and
low-risk patients. Other similar models, such as those of
Jakobsson et al,7 Anneroth et al,8 Bryne et al,9 and
Martınez–Gimeno et al,10 have also been suggested for
the same purposes. Although some studies found them
useful for prognostication of oral tongue SCC,11–13 most
models are either too cumbersome for use in clinical
diagnostics or have not shown prognostic significance,
particularly for oral tongue SCC.14–17 Consequently, we
have not used these models in our study. Similarly, we
also excluded tumor margins status because other studies
have shown that the status of the margins does not seem
to bear a strong relationship to prognosis in T1 and T2
tumors.6,18
Our group19 and others3,20 have described a strong
association between the density of cancer-associated
fibroblasts (CAFs; increased a-smooth muscle actin [a-
SMA] immunostaining) and a higher mortality in oral
tongue SCC and oral SCC. Based on our own experience,
immunohistochemistry using a-SMA antibody analysis
for CAFs is a simple method to include in any diagnostic
or prognostic protocol.
PATIENTS AND METHODS
Patients
The diagnostic histological slides of 340 patients with
T1/T2 N0M0 oral tongue SCC managed between 1979
and 2009 from the University Hospitals of Helsinki,
Oulu, Turku, Tampere, and Kuopio were collected from
the hospitals’ archives. The criteria for inclusion of cases
were as previously described15: (1) samples were from
the surgical resection specimen and (2) at least 3 different
interface tumor slides were available if the whole tumor
was not embedded. In addition, patients must not have
had any prior treatment for oral tongue SCC. One hun-
dred seven cases did not meet these criteria and were
excluded, leaving a total of 233 cases for analysis. The
use of patient samples and the data inquiry were approved
by the University Hospital Ethics Committees of all 5
hospitals and by the National Supervisory Authority for
Welfare and Health (VALVIRA).
Tumor budding, depth of invasion, and histologic risk
assessment score
All samples were evaluated in the light microscope
independently by 2 investigators (A.A. and I.O.B.), and
then jointly for consensus. A critical review of all cases
was then carried out together with an experienced head
and neck pathologist (I.L.). All 3 investigators were
blinded to the clinicopathologic data at the time of the
evaluation. Before the evaluation process, a pilot study of
30 cases had been carried out to standardize the evalua-
tion criteria for the 3 investigators (coordinated by I.L.).
Depth of invasion was measured from the surface of
the tumor to the deepest point of invasive tumor in
paraffin-embedded sections.21 The cutoff point used to
stratify the patients with oral tongue SCC into the low-
risk and high-risk tumors was 4 mm.22
Tumor budding was defined as a single cancer cell or a
cluster of <5 cancer cells in the stroma of the invasive
front.23 Tumor budding of <5 was considered low risk,
whereas that 5 was considered high risk. Slides were
scanned using a 34 microscope objective to select areas
with highest tumor budding. Budding was counted using
a 320 objective and the highest count per case was used
as the score of budding5 (Figure 1).
The histologic risk assessment score was composed of
the worst pattern of invasion (WPOI), lymphocytic host
response (LHR), and perineural invasion (PNI), as previ-
ously described6 (Figure 2A–C). High-risk WPOI was
marked by small tumor islands <15 cells and satellite
tumor(s) located at least 1 mm away from the main tumor
or the nearest satellite. This was in contrast to low-risk
WPOI, which comprised tumors with pushing borders,
finger-like growth, or large cohesive invasion. Presence
of large PNI and little or no LHR were also considered
high risk.
Immunohistochemical staining for a-SMA was per-
formed and scored as previously described.19 Each tumor
received the score according to its most intensive staining
(Figure 2D–F). For immunohistochemistry, new slides
had to be prepared, and the blocks of only 82 cases were
available for staining (T1, n 5 31 and T2, n 5 51).
Statistical analysis
The prognosis of patients in relation to the parameters
of this study was analyzed in relation to disease-specific
mortality (death from oral tongue SCC), and mortality
resulting from other causes of death. Kaplan–Meier plots
FIGURE 1. Histological appearance of tumor budding at the inva-
sive front of early oral tongue squamous cell carcinoma (SCC);
tumor budding shown by arrows as an isolated single cancer cell
or a cluster composed of <5 cancer cells. [Color figure can be
viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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were constructed to present cumulative survival outcomes
and compared using the log-rank test for both groups.
The prognostic strength of each marker was assessed
using Cox proportional hazard regression model. The
unadjusted (univariate) model was used for single param-
eters. The adjusted (multivariate) model was used for
those parameters considered to have a strong association
with prognosis. The adjusted model was fitted with cate-
gorical covariates: the age (60 years vs >60 years), the
sex, tumor grade, and center in which the patient was
managed, to assess the independent prognostic strength of
the marker. Statistical significance was set at p < .05. All
statistics were done using IBM SPSS version 20.
RESULTS
The distribution of patients by demographic and clini-
copathologic factors in the 5 centers is shown in Table 1.
The mean follow-up period was 67 months (range, 1–267
months). Fifty-five patients died of oral tongue SCC and
63 died of other causes, whereas 115 were alive at the
end of the follow-up period.
Survival outcomes
Increased tumor budding and depth of invasion were
strongly associated with increased oral tongue SCC-related
mortality (log-rank p 5 .009 and .023, respectively),
whereas a strong association was not found for HRS and
CAF density (Figure 3). The data for the 3 constituent
parameters of HRS (ie, WPOI, LHR, and PNI) were then
further analyzed separately. When WPOI was divided in a
2-tiered system (score 0 as low, and scores 1 and 3 as
high), there was a statistically significant association with
mortality from oral tongue SCC (p 5 .005; Figure 4).
LHR and PNI did not show a strong association with
mortality from oral tongue SCC when similarly grouped in
any 2-tiered system (p > .05, not shown).
In our previous study, we classified all stages of oral
tongue SCC into CAF-poor, CAF-medium, and CAF-rich
patterns for CAF density analysis (Table 1).19 However,
because this study was aimed at dividing the patients into
2 risk groups, the analysis for CAF score was modified
into a 2-tiered system combining low and intermediate
scores versus high score. For comparison with our previ-
ous work,19 we reanalyzed them with the 3-tiered system
(not shown). In both instances, we found no significant
association (p > .05). None of the analyzed histological
parameters were associated with deaths from other causes
(Figure 3).
Regression analysis
In the unadjusted model, the age of the patient, tumor
budding, and depth of invasion were the parameters that
were positively and strongly associated with mortality
from early-stage oral tongue SCC (Table 2). Analyzed
separately, WPOI was also strongly associated with mor-
tality from oral tongue SCC (Table 3). Age was the only
variable that was associated with mortality from other
causes and consequently further exploration of its effect
was considered unnecessary. However, it was still
included in the adjusted model.
In the adjusted model, increased tumor budding, depth
of invasion, and WPOI retained their strong prognostic
association with mortality because of oral tongue SCC
(Table 4).
DISCUSSION
Management of patients with oral tongue SCC is still
based mainly on the clinical (TNM) staging of the
patient, despite large numbers of reported histological,
FIGURE 2. Histologic risk assessment model, (A) worst pattern of invasion type 4 associated with weak lymphocytic host response (type 3); (B)
worst pattern of invasion type 5 (tumor satellite); and (C) perineural invasion (small nerve). Cancer associated fibroblasts, (D) poor; (E) medium; and
(F) rich. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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immunohistochemical, and molecular biomarkers in the
literature.24,25 Based on our previous findings, tumor stag-
ing may be more powerful in prognostication and treat-
ment planning for the later stages of oral tongue SCC,
and much less so for the early stages (T1/T2N0M0).12
Although a recent study11 has suggested that a more
relaxed approach to management (surgery without exten-
sive ablation of margins or use of multimodality treat-
ment) of these lesions may be as good as aggressive
treatment, there is no question that a small percentage of
patients with early oral tongue SCC constitute a high-risk
group that will benefit from multimodality treatment.
The present study assessed the effectiveness of histo-
morphologic parameters in predicting the mortality of
patients with early-stage oral tongue SCC. The purpose
was to group the patients into a high-risk category that
would benefit from multimodality treatments, and a low-
risk category in which local surgical treatment would be
sufficient. We found that the depth of invasion, tumor
budding, and WPOI were the only parameters that
independently predicted the prognosis of patients with
T1/T2N0M0 oral tongue SCC, whereas we could not find
such results with the HRS and density of CAFs.
The depth of invasion was an independent prognostic fac-
tor in early-stage oral tongue SCC. This observation confirms
several previous findings.26,27 Although various cutoff points
have been suggested in different studies, depth of invasion of
4 mm seems to be common, and the optimal point by a meta-
analytic review of the subject.22 One study that reported no
association between tumor thickness and prognosis was car-
ried out on 26 patients only, and the measurements were
taken from the base of the overlying epithelium.28 The nega-
tive findings from that study may be because of the difference
in the method of measurement or the small sample size. To
test the erratic effects of a small sample size, we analyzed 28
patients from one of our centers (Kuopio) and could not con-
firm a significant relationship between the depth of invasion
and patient mortality (not shown).
Tumor budding has been related to the prognosis of
patients in various types of epithelial cancers, such as
esophageal,29 lung,30 colorectal,23 and endometrial31 car-
cinomas. In tongue carcinoma, a recent study involving
TABLE 1. Demographic and clinicopathological features of 233 patients with early oral tongue squamous cell carcinoma (T1/T2N0M0).
Clinicopathological variable No. of patients (%) Oulu (n 5 58) Helsinki (n 5 58) Turku (n 5 52) Tampere (n 5 37) Kuopio (n5 28)
Years under review 1985–2007 1993–2003 1998–2009 1997–2007 1979–1997
Age, y
60 86 (36.9) 18 (31.0) 30 (51.7) 14 (26.9) 14 (37.8) 10 (35.7)
>60 147 (63.1) 40 (69.0) 28 (48.3) 38 (73.1) 23 (62.2) 18 (64.3)
Range 10–95 26–89 23–91 25–95 37–89 10–82
Median 65 70.0 59.5 68.5 65.0 64
Sex
Male 109 (46.8) 24 (41.4) 29 (50.0) 28 (53.8) 13 (35.1) 15 (53.6)
Female 124 (53.2) 34 (58.6) 29 (50.0) 24 (46.2) 24 (64.9) 13 (46.4)
Grade
I 83 (35.6) 27 (46.6) 19 (32.8) 9 (17.3) 17 (45.9) 11 (39.3)
II 109 (46.8) 29 (50.0) 26 (44.8) 25 (48.1) 15 (40.5) 14 (50.0)
III 41 (17.6) 2 (3.4) 13 (22.4) 18 (34.6) 5 (13.5) 3 (10.7)
Clinical stage
I 113 (48.5) 24 (41.4) 27 (46.6) 33 (63.5) 16 (43.2) 13 (46.4)
II 120 (51.5) 34 (58.6) 31 (53.4) 19 (36.5) 21 (56.8) 15 (53.6)
Recurrence
Absent 160 (68.6) 36 (62.1) 41 (70.7) 38 (73.1) 28 (76.0) 17 (60.7)
Present 73 (31.4) 22 (37.9) 17 (29.3) 14 (26.9) 9 (24.0) 11 (39.3)
Status
Alive 115 (49.4) 32 (55.2) 25 (43.1) 31 (59.6) 17 (45.9) 10 (35.7)
Dead of oral tongue SCC 55 (23.6) 9 (15.5) 16 (27.6) 13 (25.0) 7 (18.9) 10 (35.7)
Dead of other causes 63 (27.0) 17 (29.3) 17 (29.3) 8 (15.4) 13 (35.2) 8 (28.6)
Tumor budding
Low (<5 buds) 152 (65.2) 38 (65.5) 36 (62.1) 41 (78.8) 25 (67.6) 12 (42.9)
High (5 buds) 81 (34.8) 20 (34.5) 22 (37.9) 11 (21.2) 12 (32.4) 16 (57.1)
Tumor depth
Low (<4 mm) 80 (34.3) 20 (34.5) 16 (27.6) 32 (61.5) 7 (18.9) 5 (17.9)
High (4 mm) 153 (65.7) 38 (65.5) 42 (72.4) 20 (38.5) 30 (81.1) 23 (82.1)
Histologic risk assessment score
Low risk (<3) 111 (47.6) 35 (60.3) 34 (58.6) 14 (26.9) 19 (51.4) 9 (32.1)
High risk (3) 122 (52.4) 23 (39.7) 24 (41.4) 38 (73.1) 18 (48.6) 19 (67.9)
CAF score*
Low (0–1) 27 (32.9) 9 (24.3) 6 (33.3) 0 0 12 (44.4)
Medium (2–3) 40 (48.8) 23 (62.2) 8 (44.5) 9 (33.3)
High (4) 15 (18.3) 5 (13.5) 4 (22.2) 6 (22.2)
Abbreviations: SCC, squamous cell carcinoma; CAF, cancer-associated fibroblast.
*Only 82 cases (37 from Oulu, 18 from Helsinki, and 27 from Kuopio) were available for this analysis as some blocks no longer have tumor tissue.
ALMANGUSH ET AL.
814 HEAD & NECK—DOI 10.1002/HED JUNE 2014
patients with tumors of all clinical stages, and of both
oral and posterior locations, found tumor budding to be
an adverse prognostic parameter.5 Here, we could demon-
strate that tumor budding and depth of invasion independ-
ently predicted the mortality of patients with oral tongue
SCC with a T1/T2N0M0 tumor.
The HRS model studies by Brandwein–Gensler et al6,15
have been performed on a tumor material containing all
clinical stages of oral SCC, similarly to those other stud-
ies that have replicated the findings.32,33 Our results on
T1 to T2N0M0 oral tongue SCC indicate that the HRS in
our hands offered little or no insight into the prognosis in
FIGURE 3. Kaplan–Meier curves describing the cumulative mortality of patients during the follow-up period from oral tongue squamous cell carci-
noma (A1–D1) and from other causes of death (A2–D2). The markers were tumor budding (high 5 5 buds; low 5 <5 buds; A1, A2); tumor depth
(high 5 4 mm; low 5 <4 mm; B1, B2); histologic risk score (low 5 <3; high 5 3; C1, C2); and cancer-associated fibroblast (CAF) score (high
5 high CAF density; low 5 medium and low CAF density; D1, D2). [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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FIGURE 4. Kaplan–Meier curves for cumulative mortality of patients from oral tongue squamous cell carcinoma (SCC; A1), and from other causes
(A2) in relation to the worst pattern of invasion (WPOI). The patients with high WPOI (<15 cells in an invasive island, single cells, or satellite tumor
cells) were associated with a higher mortality compared to those with a low WPOI score (pushing borders, finger-like, and cohesive invasion).
[Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
TABLE 2. Unadjusted (univariate) Cox proportional hazard models for all variables analyzed fitted for mortality because of oral tongue squamous cell carci-
noma and mortality because of other causes.
Mortality related to oral tongue SCC Mortality related to other causes
Variable Events (55) HR (95% CI) p value Events (63) HR (95% CI) p value
Age
60 13 1 17 1
>60 42 2.44 1.31–4.56 .005 46 2.77 1.57–4.87 .001
Sex
Male 20 1 34 1
Female 35 0.67 0.39–1.16 .16 29 1.59 0.96–2.61 .07
Grade
I 15 1 23 1
II 29 1.62 0.87–3.03 .13 30 1.17 0.68–2.01 .57
III 11 1.92 0.88–4.18 .10 10 1.25 0.60–2.64 .55
Clinical stage
I 22 1 27 1
II 33 1.50 0.87–2.57 .14 36 1.42 0.86–2.34 .17
Centers
Oulu 9 1 17 1
Helsinki 16 0.93 0.34–2.48 .87 17 1.12 0.54–2.31 .77
Kuopio 10 1.40 0.58–3.41 .46 8 0.78 0.38–1.60 .49
Turku 13 2.26 0.86–5.94 .10 8 1.05 0.44–2.54 .91
Tampere 7 2.72 1.07–6.92 .035 13 1.86 0.73–4.73 .19
Tumor budding
Low (<5) 27 1 41 1
High (5) 28 2.00 1.17–3.40 .01 22 0.90 0.53–1.51 .68
Tumor depth
Low (<4) 10 1 23 1
High (4) 45 2.17 1.09–4.31 .027 40 0.76 0.45–1.26 .29
Histologic risk score
Low risk (<3) 25 1 33 1
High risk (3) 30 1.24 0.73–2.11 .43 30 0.96 0.59–1.58 .88
CAF score*
Low 1 medium (<4) 17 1 17 1
High (4) 5 1.53 0.56–4.14 .41 6 2.17 0.85–5.54 .10
Abbreviations: SCC, squamous cell carcinoma; HR, hazard ratio; CI, confidence interval.
The figures in boldface represent significant association with mortality.
*Only 82 cases were available for cancer-associated fibroblast (CAF) score analyses.
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this subset of patients. HRS did not stratify these patients
into risk groups. The inclusion of T1 to T4 tumors in
studies validating the model may have contributed to the
positive predictive value of the model. Moreover, the
inclusion of SCCs from all oral subsites together with the
oropharynx, which appear biologically different from oral
tongue SCC, may also have contributed to those results.
However, further exploration of the components of the
HRS showed that unfavorable WPOI is strongly associ-
ated with mortality. Several studies have previously con-
firmed the relationship of unfavorable WPOI with poor
prognosis in oral SCC.34–36 A recent study on oral tongue
SCC did not find any correlation of WPOI with prognosis
or response to treatment, but a dense LHR was associated
with complete response to therapy. This latter study com-
prised all stages of oral tongue SCC, in addition to using
only biopsy specimens.37 These 2 factors may have influ-
enced their findings.
In our previous study,19 we showed that high density of
CAFs, as demonstrated by a-SMA immunohistochemis-
try, is a strong poor prognosticator in oral tongue SCC.
That finding was based on a study material comprising
all stages of oral tongue SCC. A review of studies on oral
SCC has suggested that CAFs play a significant role in
the adverse prognosis of epithelial oral cancers.38 We
were unable to replicate this finding in the present cohort
of patients with T1/T2N0M0 SCC. Analyzing our present
finding (CAFs vs oral tongue SCC outcome) based on the
3-tier system (low, medium, and high), we noted that our
cumulative hazard (Kaplan–Meier) curve followed a trend
similar to the previous study but did not achieve statisti-
cal significance in the present study. Our finding showed
that in T1/T2N0M0 oral tongue SCC, it is unusual to
have a high density of CAFs in these tumors. It is con-
ceivable that CAF density is a time-dependent phenom-
enon in oral tongue SCC as CAFs are believed to be
recruited into the tumor from a variety of sources, and
not only from local resting fibroblasts.39 Our previous
finding might have been influenced in part by the inclu-
sion of patients with stages III and IV oral tongue SCC.
One of the arguments against the usefulness of the con-
ventional histological and morphological parameters is
that they can be best evaluated only after the patient has
undergone surgical treatment of the tumor. Therefore, the
treatment already planned may in some cases have to be
modified based on the results obtained from the surgical
resection specimen. However, a preoperative determina-
tion of tumor depth through MRI and ultrasonography has
been suggested by several groups.26,40 Measurement of
tumor depth may therefore be advocated as part of a rou-
tine clinical workup of the patient. It may be helpful
toward stratification of patients in early-stage oral tongue
SCC and in treatment planning with further reassurance
by examining the tumor budding and WPOI from the sur-
gical specimen. In addition, based on this study, we sug-
gest that the predictive value of measuring tumor depth,
budding, or WPOI from frozen sections of T1/T2 N0 oral
tongue SCC during the surgery should be studied. The
results obtained should then be compared with those of
postoperative surgical paraffin-embedded tumors. In case
this unrefined estimation of the above parameters from a
frozen section assigns an outcome similar to that in the
evaluation of the paraffin sections, it could be used in
treatment planning. Specifically, in aggressive T1/T2 N0
cases (ie, depth of 4 mm, budding of 5 clusters at the
invasive front or high-risk WPOI), evacuation of the neck
TABLE 3. Analysis (unadjusted Cox proportional hazard models) of the association of the components of the histologic risk assessment score and patients’
mortality.
Mortality related to oral tongue SCC Mortality related to other causes
Variable Events (55) HR (95% CI) p value Events (63) HR (95% CI) p value
WPOI
Low 4 1 18 1
High 51 3.86 1.39–10.68 0.009 45 0.77 0.45–1.34 0.36
LHR
Low 34 1 40 1
High 21 1.56 0.87–2.79 0.13 23 1.86 1.03–3.36 0.04
PNI
None 45 1 52 1
Present 10 1.31 066–2.61 0.44 11 1.06 0.56–2.05 0.85
Abbreviations: SCC, squamous cell carcinoma; HR, hazard ratio; CI, confidence interval; WPOI, worst pattern of invasion; LHR, lymphocytic host response; PNI, perineural invasion.
The figures in boldface represent significant association with mortality.
TABLE 4. Adjusted (multivariate) Cox proportional hazard model for mor-
tality because of oral tongue squamous cell carcinoma. Each variable
was entered into a model comprising age (60 and >60), sex, grade,
and centers where patients were managed.
HR 95% CI p value
Tumor budding
<5 1
5 2.04 1.17–3.55 0.01
Tumor depth
<4 mm 1
4 mm 2.55 1.25–5.20 0.01
WPOI
0 (low) 1
1 or 3 (high) 4.47 1.59–12.51 0.004
Abbreviations: SCC, squamous cell carcinoma; HR, hazard ratio; CI, confidence interval;
WPOI, worst pattern of invasion; LHR, lymphocytic host response; PNI, perineural invasion.
The figures in boldface represent significant association with mortality.
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lymph nodes during the primary surgery should be con-
sidered as a routine treatment plan. Furthermore, the use
of multimodality treatment, including radiation and/or
chemotherapy, should also be considered in these latter
patients.
In conclusion, there are patients with T1/T2N0M0 SCC
with aggressive high-risk disease for whom the use of
multimodality treatment would be beneficial regardless of
treatment approaches. Those patients could be selected by
evaluating the depth of invasion, tumor budding, or
WPOI, all parameters that can be easily and rapidly ana-
lyzed from the routine hematoxylin-eosin–stained tumor.
Moreover, this study was based on a large patient mate-
rial from the central university hospitals in Finland, and
our findings may be a step forward in individualized
patient management in early tongue cancer.
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